Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Galmed Pharmaceuticals

0.5751
+0.02063.72%
Volume:35.60K
Turnover:19.94K
Market Cap:3.15M
PE:-0.17
High:0.5751
Open:0.5423
Low:0.5300
Close:0.5545
52wk High:3.50
52wk Low:0.5025
Shares:5.48M
Float Shares:2.02M
Volume Ratio:0.38
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4400
EPS(LYR):-8.0757
ROE:-46.34%
ROA:-20.90%
PB:0.16
PE(LYR):-0.07

Loading ...

OverviewCompanyNewsFilings

Galmed Pharmaceuticals Unveils Promising Synergistic Results for Aramchol, Stivarga, and Metformin in GI Cancer Models

Reuters
·
Nov 17, 2025

Galmed Announces Top-Line Results in Oncology Moa Studies: a 3-Drug Combination of Aramchol, Stivarga® and Metformin Significantly Enhanced Gi Tumor Cells, Killing in-Vivo and in-Vitro

THOMSON REUTERS
·
Nov 17, 2025

Galmed Pharmaceuticals Ltd. Announces Proxy Proposals for Upcoming October 2025 Shareholder Meeting

Reuters
·
Sep 23, 2025

Galmed Pharmaceuticals Schedules Annual General Meeting for October 2025

TIPRANKS
·
Sep 20, 2025

Galmed Pharmaceuticals Q2 EPS $(0.63) Beats $(0.83) Estimate

Benzinga
·
Aug 28, 2025

Galmed Pharmaceuticals Reports Q2 2025 Financial Results: Net Loss Widens to $2.5 Million, EPS at $0.63, R&D Expenses Double

Reuters
·
Aug 28, 2025

Galmed Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 28, 2025

Analyst Rate

Hold
Buy
0.00%
Hold
100.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 26, 2025 Pre-Market
Financial Report Announcement
Aug 28, 2025 Pre-Market
Financial Report Announcement
May 22, 2025 Pre-Market
Financial Report Announcement
Apr 02, 2025 Post Market
Financial Report Announcement
Nov 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.17
Current
-0.87
Sector Average
69.88%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.17
Maximum
-0.07
+1 STD
-0.09
Minimum
-3.49
-1 STD
-1.64
Average
-0.87

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.